Off‐label use of dupilumab for the treatment of moderate to severe atopic dermatitis in children aged below 6 years of age: a case series-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Off‐label use of dupilumab for the treatment of moderate to severe atopic dermatitis in children aged below 6 years of age: a case series

Published:2021-10-19 Issue:2 Volume:47 Page:423-425
ISSN:0307-6938
Container-title:Clinical and Experimental Dermatology
language:en
Short-container-title:Clin Experimental Derm

Author:

Da J.¹,Ali K.²,Lu K.³,Lou H.²,Qiu Y.²,Shan J.²,Wu L.¹^ORCID

Affiliation:

1. Department of Dermatology Affiliated Hangzhou First People's Hospital Zhejiang University School of Medicine Hangzhou China

2. Department of Dermatology Affiliated Hangzhou First People's Hospital, Zhejiang Chinese Medical University HangzhouChina

3. Department of Oncological Surgery Affiliated Hangzhou First People's Hospital Zhejiang University School of Medicine Hangzhou China

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ced.14925

Reference6 articles.

1. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three

2. Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis

3. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

4. Dupilumab: A New Paradigm for the Treatment of Allergic Diseases

5. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of systemic treatments on pruritus associated with atopic dermatitis: A systematic review in pediatric patients;Pediatric Dermatology;2023-11-28

2. Effectiveness of Dupilumab in Pediatric Patient With Prurigo Nodularis-Like Atopic Dermatitis;Dermatitis®;2023-04-01

3. Dupilumab en niños y adolescentes con dermatitis atópica: serie de casos y revisión de la literatura;Piel;2023-04

4. Efficacy of Dupilumab in Children 6 Months to 11 Years Old With Atopic Dermatitis: A Retrospective Real-World Study in China;Dermatitis®;2023-02-17

5. Dupilumab in the Treatment of Cheilitis in Atopic Dermatitis Patients;Clinical, Cosmetic and Investigational Dermatology;2022-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3